All Stories

  1. A literature review of the pharmacokinetic profiles of 20 commonly prescribed antihypertensive medications for use in chemical adherence testing
  2. DEVELOPMENT OF A NOVEL DIGITAL PHARMACOKINETICS APP FOR CARDIOVASCULAR DRUGS
  3. Prediction of neutrophil nadir and recovery following paediatric haematopoietic cell transplantation with busulfan conditioning
  4. Chemical Adherence Testing for Assessing Adherence to Antihypertensive Medications: A Systematic Review and Meta-Analysis of Prevalence of Nonadherence
  5. Engineered Receptor Capture Combined with Mass Spectrometry Enables High-Throughput Detection and Quantitation of SARS-CoV-2 Spike Protein
  6. Effectiveness of biofeedback on blood pressure in patients with hypertension: systematic review and meta-analysis
  7. A high throughput immuno-affinity mass spectrometry method for detection and quantitation of SARS-CoV-2 nucleoprotein in human saliva and its comparison with RT-PCR, RT-LAMP, and lateral flow rapid antigen test
  8. An Innovative Chemical Adherence Test Demonstrates Very High Rates of Nonadherence to Oral Cardio-Metabolic Medications
  9. 128 Medication non-adherence assessed using liquid chromatography tandem mass spectrometry in patients with chronic heart failure
  10. Operation Moonshot: rapid translation of a SARS-CoV-2 targeted peptide immunoaffinity liquid chromatography-tandem mass spectrometry test from research into routine clinical use
  11. High non-adherence rates to secondary prevention by chemical adherence testing in patients with TIA
  12. DEVELOPMENT OF A TARGETED PROTEOMICS ASSAY FOR QUANTIFICATION OF ANGIOTENSIN PEPTIDES IN THE RENIN ANGIOTENSIN ALDOSTERONE SYSTEM
  13. THE PHARMACOKINETIC PARAMETERS DATA OF THE 20 MOST COMMONLY PRESCRIBED ANTIHYPERTENSIVE MEDICATIONS
  14. Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing
  15. Non‐adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography‐tandem mass spectrometry (results of a prospective multicentre study)
  16. Cov-MS: A Community-Based Template Assay for Mass-Spectrometry-Based Protein Detection in SARS-CoV-2 Patients
  17. Urine Concentration Does Not Affect Biochemical Testing for Non-adherence
  18. Cov-MS: a community-based template assay for clinical MS-based protein detection in SARS-CoV-2 patients
  19. 1424The diagnosis of non-adherence in hypertension using a urine biochemical screen is unaffected by drug pharmacokinetics
  20. Expect the unexpected: presenting research leads to unforeseen gains
  21. Objective measures of non-adherence in cardiometabolic diseases: a review focused on urine biochemical screening
  22. Biochemical Urine Testing of Adherence to Cardiovascular Medications Reveals High Rates of Nonadherence in People Attending Their Annual Review for Type 2 Diabetes
  23. Cardiovascular Medication Stability in Urine for Non-Adherence Screening by LC–MS-MS